|
4Z7U
S13 complex
Deposited 2015-04-08
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain B
1–192(192 aa)
Fragment:UNP residues 1-192
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;140 mM Na-acetate, 0.1 M Bis-Tris-Propane pH 7.5, 15% PEG8000
|
Resolution 2.70 Å
R-free 0.220
|
|
4Z7U
S13 complex
Deposited 2015-04-08
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain D
1–192(192 aa)
Fragment:UNP residues 1-192
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;140 mM Na-acetate, 0.1 M Bis-Tris-Propane pH 7.5, 15% PEG8000
|
Resolution 2.70 Å
R-free 0.220
|
|
4Z7V
L3-12 complex
Deposited 2015-04-08
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain B
1–192(192 aa)
Fragment:UNP residues 1-192
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;80 mM Na-acetate, 0.1 M Bis-Tris-Propane pH 6.5, 16% PEG8000
|
Resolution 2.65 Å
R-free 0.226
|
|
4Z7V
L3-12 complex
Deposited 2015-04-08
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain D
1–192(192 aa)
Fragment:UNP residues 1-192
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;80 mM Na-acetate, 0.1 M Bis-Tris-Propane pH 6.5, 16% PEG8000
|
Resolution 2.65 Å
R-free 0.226
|
|
4Z7W
T316 complex
Deposited 2015-04-08
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain B
1–192(192 aa)
Fragment:UNP residues 1-192
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;0.32 M (NH4)2SO4, 0.1 M HEPES pH 7.8, 20% PEG3350
|
Resolution 2.89 Å
R-free 0.247
|
|
4Z7W
T316 complex
Deposited 2015-04-08
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain D
1–192(192 aa)
Fragment:UNP residues 1-192
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;0.32 M (NH4)2SO4, 0.1 M HEPES pH 7.8, 20% PEG3350
|
Resolution 2.89 Å
R-free 0.247
|
|
5KSA
Bel602-DQ8.5-glia-gamma1 complex
Deposited 2016-07-08
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain B
1–192(192 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
CA CALCIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;0.1 M Ca-Acetate, 21 % PEG3350, Tris pH 8.0
|
Resolution 2.00 Å
R-free 0.206
|
|
5KSB
T15-DQ8.5-glia-gamma1 complex
Deposited 2016-07-08
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain B
1–192(192 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;8% Tacsimate pH 7.5, 20% PEG3350
|
Resolution 2.90 Å
R-free 0.254
|
|
5KSB
T15-DQ8.5-glia-gamma1 complex
Deposited 2016-07-08
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain D
1–192(192 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;8% Tacsimate pH 7.5, 20% PEG3350
|
Resolution 2.90 Å
R-free 0.254
|
|
6XCO
Immune receptor complex
Deposited 2020-06-08
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
1–192(192 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
GOL GLYCEROL × 6
CAC CACODYLATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;293.15 K;0.1 M calcium acetate, 0.1 M sodium cacodylate pH 5.5, 13% polyethylene glycol (PEG) 20,000
|
Resolution 2.90 Å
R-free 0.247
|
|
6XCP
Immune receptor complex
Deposited 2020-06-08
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–192(192 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
GOL GLYCEROL × 1
PO4 PHOSPHATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;13% PEG 8000, 0.2M Potassium dihydrogen phosphate
|
Resolution 3.30 Å
R-free 0.268
|
|
8VCX
Human TCR A2.13 in complex with DQ8-InsCpep
Deposited 2023-12-14
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain B
1–192(192 aa)
|
Not recorded
|
PO4 PHOSPHATE ION × 1
GOL GLYCEROL × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293.15 K;0.2 M Potassium sodium tartrate, 24% PEG 3350
|
Resolution 2.59 Å
R-free 0.238
|
|
8VCY
Human TCR A2.13 in complex with DQ8-InsC8-15NPY
Deposited 2023-12-14
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain B
1–192(192 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
GOL GLYCEROL × 5
PO4 PHOSPHATE ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293.15 K;0.2 M Potassium sodium tartrate, 14% PEG 20,000 with seeding C8 silver bullet (Hampton Research)
|
Resolution 2.60 Å
R-free 0.225
|
|
8VD0
Human TCR ET650-4 in complex with DQ8-InsC8-15-IAPP2
Deposited 2023-12-14
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–192(192 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
GOL GLYCEROL × 4
PO4 PHOSPHATE ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293.15 K;0.2 M K Na tartrate, 15% w/v PEG 20,000 with seeding and additive C8 silver bullet
|
Resolution 2.40 Å
R-free 0.220
|
|
8VD0
Human TCR ET650-4 in complex with DQ8-InsC8-15-IAPP2
Deposited 2023-12-14
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain H
1–192(192 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
GOL GLYCEROL × 8
PO4 PHOSPHATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293.15 K;0.2 M K Na tartrate, 15% w/v PEG 20,000 with seeding and additive C8 silver bullet
|
Resolution 2.40 Å
R-free 0.220
|
|
8VD2
Human TCR ET650-4 in complex with DQ8-InsC8-15-IAPP1
Deposited 2023-12-14
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain B
1–192(192 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293.15 K;0.2 M potassium dihydrogen phosphate (KH2PO4), 15% w/v PEG 20,000 with seeding and additive 30 mM MnCl2
|
Resolution 2.90 Å
R-free 0.259
|
|
8VDD
Crystal structure of Proinsulin C-peptide bound to HLA-DQ8
Deposited 2023-12-14
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–192(192 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293.15 K;0.2 M K Na tartrate, 14% w/v PEG 20,000 with seeding and additive C8 silver bullet
|
Resolution 2.60 Å
R-free 0.280
|
|
8VDU
Crystal structure of hybrid insulin peptide (InsC8-15-IAPP74-80) bound to HLA-DQ8
Deposited 2023-12-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 12
PDB declaration: dodecameric
|
Chain B
1–192(192 aa)
Chain E
1–192(192 aa)
Chain H
1–192(192 aa)
Chain K
1–192(192 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
PEG DI(HYDROXYETHYL)ETHER × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293.15 K;0.2 M Monopotassium phosphate, 17% PEG 8K
|
Resolution 3.50 Å
R-free 0.246
|